Gene · 10038
Papers2,674
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,674
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Maintenance with niraparib in patients with stage III, stage IV, chemo-naïve recurrent or platinum-sensitive recurrent uterine serous carcinoma: study protocol for a phase II clinical trial. | BMJ Open | 2025 | 40473279 | PubTator, text mining | PubMed |
| Approaches to repurposing reverse transcriptase antivirals in cancer. | Br J Clin Pharmacol | 2025 | 40432477 | PubTator, text mining | PubMed |
| Widespread false negatives in DNA-encoded library data: how linker effects impair machine learning-based lead prediction. | Chem Sci | 2025 | 40395382 | PubTator, text mining | PubMed |
| Adenosine diphosphate-ribosylation greatly affects proteins function: a focus on neurodegenerative diseases. | Front Aging Neurosci | 2025 | 40370754 | PubTator, text mining | PubMed |
| Joining of DNA breaks- interplay between DNA ligases and poly (ADP-ribose) polymerases. | DNA Repair (Amst) | 2025 | 40347914 | PubTator, text mining | PubMed |
| Identification of hub genes related to DNA damage response in asthma via combinative bioinformatics strategy. | J Int Med Res | 2025 | 40288048 | PubTator, text mining | PubMed |
| Trabectedin Induces Synthetic Lethality via the p53-Dependent Apoptotic Pathway in Ovarian Cancer Cells Without BRCA Mutations When Used in Combination with Niraparib. | Int J Mol Sci | 2025 | 40243501 | PubTator, text mining | PubMed |
| Engaging an engineered PARP-2 catalytic domain mutant to solve the complex structures harboring approved drugs for structure analyses. | Bioorg Chem | 2025 | 40228437 | PubTator, text mining | PubMed |
| Prognostic Value of PARP1 and PARP2 Copy Number Alterations in Prostate Cancer. | Lab Invest | 2025 | 40210166 | PubTator, text mining | PubMed |
| Employing a Highly Potent Fluorescence Probe to Discover a Poly (Adenosine Diphosphate-ribose) Polymerases-1/2 Binder and the Complex Structures Analysis. | ChemMedChem | 2025 | 40204633 | PubTator, text mining | PubMed |
| PARP inhibitors in ovarian cancer: Mechanisms of resistance and implications to therapy. | DNA Repair (Amst) | 2025 | 40203475 | PubTator, text mining | PubMed |
| HPF1 Regulates Pol β Efficiency in Nucleosomes via the Modulation of Total Poly(ADP-Ribose) Synthesis. | Int J Mol Sci | 2025 | 40076422 | PubTator, text mining | PubMed |
| PARP2 Catalytic Activity Is Allosterically Stimulated by Binding to the c-KIT1 G-Quadruplex. | ACS Omega | 2025 | 40060879 | PubTator, text mining | PubMed |
| PARP-2 acts on ILK signaling and pharmacological targeting of PARP-2 ameliorate endometriosis in a mouse model. | Biochem Biophys Res Commun | 2025 | 40036901 | PubTator, text mining | PubMed |
| Duplexed CeTEAM drug biosensors reveal determinants of PARP inhibitor selectivity in cells. | J Biol Chem | 2025 | 40021124 | PubTator, text mining | PubMed |
| XRCC1 mediates PARP1- and PAR-dependent recruitment of PARP2 to DNA damage sites. | Nucleic Acids Res | 2025 | 39970298 | PubTator, text mining | PubMed |
| Parps in immune response: Potential targets for cancer immunotherapy. | Biochem Pharmacol | 2025 | 39965743 | PubTator, text mining | PubMed |
| Regulatory and Catalytic Domains of Poly(ADP-ribose) Polymerases Cross-Complement for DNA-Break-Dependent Allosteric Stimulation of Catalytic Activity. | ACS Chem Biol | 2025 | 39935093 | PubTator, text mining | PubMed |
| Multi-stage structure-based virtual screening approach combining 3D pharmacophore, docking and molecular dynamic simulation towards the identification of potential selective PARP-1 inhibitors. | BMC Chem | 2025 | 39893479 | PubTator, text mining | PubMed |
| A PARP2 active site helix melts to permit DNA damage-induced enzymatic activation. | Mol Cell | 2025 | 39889708 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10038/papers?page=6